Hanbang Body-fluid Research Center, Wonkwang University, Iksan, Jeonbuk, Korea.
J Med Food. 2012 Feb;15(2):169-79. doi: 10.1089/jmf.2010.1222. Epub 2011 Nov 14.
Cynanchum wilfordii is used in traditional Chinese medicine with almost all parts of this plant considered beneficial for various vascular diseases. This study was performed to evaluate the effect of an ethanol extract of C. wilfordii (ECW) on vascular dysfunction in apolipoprotein E (apoE)(-/-) mice fed with high fat/cholesterol diets (HFCDs). The apoE(-/-) mice were fed HFCD consisting of 7.5% cocoa butter and 1.25% cholesterol, with or without 100 or 200 mg/day/kg ECW. Chronic ECW treatment significantly lessened the level of low-density lipoprotein (P<.05) and elevated that of high-density lipoprotein-cholesterol (P<.01). Chronic ECW treatment normalized the HFCD-induced increase in systolic blood pressure, maintained smooth and soft intimal endothelial layers, and decreased intima-media thickness in aortic sections of HFCD-fed apoE(-/-) mice. ECW significantly restored the diet-induced decrease in vasorelaxation response to acetylcholine; however, the response to sodium nitroprusside did not change. ECW clearly restored the HFCD-induced reduction in endothelial nitric oxide synthase expression levels in aortic tissue, leading to decreased vascular inflammation through an inhibition of cellular adhesion molecules such as E-selectin, vascular cell adhesion molecule-1, and intracellular adhesion molecule-1 as well as endothelin-1 (ET-1) expression. In conclusion, ECW ameliorates endothelial dysfunction via improvement of the nitric oxide/cyclic GMP signaling pathway in a diet/genetic model of hyperlipidemia. ECW also substantially inhibited the development of atherosclerosis, possibly by inhibiting ET-1, cell adhesion molecules, and lesion formation, suggesting a vascular protective role for this herb in the treatment and prevention of atherosclerotic vascular disease.
白首乌被广泛应用于传统中医,其全草各部位皆有益于治疗多种血管疾病。本研究旨在评估白首乌乙醇提取物(ECW)对高脂高胆固醇饮食(HFCD)喂养的载脂蛋白 E(apoE)(-/-)小鼠血管功能障碍的影响。apoE(-/-)小鼠喂食 HFCD,其中包含 7.5%可可脂和 1.25%胆固醇,同时喂食 100 或 200mg/kg/天的 ECW 或不喂食任何药物。慢性 ECW 治疗显著降低了低密度脂蛋白(LDL)的水平(P<.05),提高了高密度脂蛋白胆固醇(HDL-C)的水平(P<.01)。慢性 ECW 治疗使 HFCD 诱导的收缩压升高恢复正常,维持主动脉切片中层光滑柔软的内皮层,并降低 HFCD 喂养的 apoE(-/-)小鼠的动脉中层厚度。ECW 显著恢复了饮食诱导的乙酰胆碱引起的血管舒张反应;然而,对硝普钠的反应没有变化。ECW 明显恢复了 HFCD 诱导的主动脉组织内皮型一氧化氮合酶表达水平的降低,通过抑制细胞黏附分子(如 E-选择素、血管细胞黏附分子-1 和细胞间黏附分子-1)和内皮素-1(ET-1)的表达,从而减少血管炎症。总之,ECW 通过改善一氧化氮/环鸟苷酸信号通路改善高脂血症的饮食/遗传模型中的内皮功能障碍。ECW 还显著抑制动脉粥样硬化的发展,可能是通过抑制 ET-1、细胞黏附分子和病变形成,这表明该草药在治疗和预防动脉粥样硬化血管疾病方面具有血管保护作用。